androgenetic alopecia
Conditions
Interventions
Botulinum toxin injection side:Botulinum toxin is injected intradermally at a density of 2u/cm2 for a total of 40-50u of Botulinum toxin at the edges and center of the balding area prior to surgery.
Saline injection side:Preoperative injection of equal amounts of saline at the edges and center of the balding area
Sponsors
West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: ? Patients who are 18 years of age or older ? Patients diagnosed with androgenetic alopecia who are eligible for hair transplantation. ? Patients with no history of treatment with known interfering botulinum toxin medications within the past 6 months. ? Patients who are willing and able to complete re-injection at 3 months and 6 months after the first injection and follow-up at 9 months after the first injection. Patients who are willing and able to complete re-injection at 3 months and 6 months after the first injection and follow-up at 9 months after the first injection ? Patients with normal Chinese or English reading and comprehension skills. ? Patients with normal Chinese or English reading and comprehension ability ? Patients who are not pregnant or breastfeeding.
Exclusion criteria
Exclusion criteria: ? Patients presenting with severe visceral, eye or skin diseases were excluded; ? Diseases of the neuromuscular system; ? Inflammation, infection or unhealed wounds of the skin around the head injection site; ? Systemic treatment with glucocorticoids or other immunosuppressive and immunomodulatory agents in the past 3 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hair count; | — |
Secondary
| Measure | Time frame |
|---|---|
| Treatment Effectiveness Score;Patient satisfaction rating; | — |
Countries
China
Contacts
Public ContactShu Zhang
Department of Dermatology, West China Hospital, Sichuan University.
Outcome results
None listed